Effect of ozone on airway inflammation in allergic asthmatics treated with omalizumab
Phase of Trial: Phase IV
Latest Information Update: 27 Nov 2014
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 22 Feb 2009 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 22 Feb 2009 Actual patient number (1) added as reported by ClinicalTrials.gov.